Category: Clinical Outcomes

Nothing found.

Heartflow One

Platform Overview
Roadmap Analysis
FFR_CT Analysis
Plaque Analysis
Support

Why CCTA

CCTA Advantage
Clinical Evidence
Clinical Research
Reimbursement

For Patients

Understanding CAD
Why Heartflow
Patient Stories

About

About Us
Careers
Contact

Investors

Overview
News & Events
Stock Information
Corporate Governance
Financial Information
IR Resources

Resources

CCTA Resources

Login

Heartflow One

Platform Overview
Roadmap Analysis
FFR_CT Analysis
Plaque Analysis
Support

Why CCTA

CCTA Advantage
Clinical Evidence
Clinical Research
Reimbursement

For Patients

Understanding CAD
Why Heartflow
Patient Stories

About

About Us
Newsroom
Careers
Contact

Resources

CCTA Resources

Investors

Overview
News & Events
Stock Information
Corporate Governance
Financial Information
IR Resources

Login

Indications
Privacy Policy
Terms of Use
Modern Slavery Statement
Carbon Reduction Plan
Accessibility
Sitemap

Heartflow Analysis consists of four main functions; FFR_CT, Planner, Roadmap, and Plaque. All four functions are cleared for clinical use in 43 countries/regions, including the United States, United Kingdom and Europe. Only FFR_CT and Planner functions are cleared for clinical use in Canada and Japan. Please see Heartflow Analysis Indications for Use and Instructions for Use for more information.

© 2026 Heartflow, Inc. | Heartflow and the Heartflow logo are registered trademarks of Heartflow, Inc. Additionally, Roadmap is claimed as a trademark of Heartflow, Inc. www.heartflow.com | 331 E Evelyn Ave, Mountain View, CA 94041